AI needs a reality check

AI companies love to make bold claims about healthcare. Alphabet’s Isomorphic tells us that “frontier AI can unlock deeper scientific insights, faster breakthroughs, and life-changing medicines.” Lila confidently markets its AI as a tool for “faster discovery for every field where breakthrough science matters.” And they’re spending as though they believe the hype. Anthropic recently acquired stealth startup Coefficient Bio for $400 million. But there’s only one true test of...